IHC · Independence Holding Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Revenue | $443.86M | $374.45M | $350.77M | $320.49M | $311.00M | $532.87M |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $205.80M | $174.98M | $169.03M | $157.10M | $132.17M | $172.18M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $4.62M | $3.20M | $2.85M | $1.92M | $1.83M | $3.06M |
| Operating Income | $29.85M | $25.35M | $37.54M | $28.34M | $32.06M | $48.19M |
| Interest Expense | - | - | - | $0 | $1.53M | $1.80M |
| Income Tax | $10.73M | $12.66M | $8.49M | ($13.79M) | $9.55M | $17.67M |
| Net Income | $18.88M | $12.40M | $28.48M | $42.04M | $123.30M | $29.94M |
| EPS - Basic | $1.28 | $0.83 | $1.92 | $2.67 | $7.18 | $1.73 |
| EPS - Diluted | $1.28 | $0.83 | $1.89 | $2.63 | $7.09 | $1.71 |
Balance Sheet
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $72.09M | $21.09M | $26.17M | $26.46M | $22.01M | $19.17M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - |
| Total Assets | $1.08B | $1.05B | $1.04B | $1.04B | $1.13B | $1.20B |
| Current Liabilities | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $611.04M | $592.35M | $583.90M | $604.32M | $695.21M | $865.26M |
| Stockholders' Equity | $469.76M | $459.69M | $448.75M | $431.54M | $436.56M | $323.35M |
| Retained Earnings | $399.27M | $386.86M | $380.43M | $356.38M | $315.92M | $194.45M |
Cash Flow
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $51.42M | $39.17M | $36.02M | $28.60M | ($31.00M) | ($164.72M) |
| Investing Cash Flow | $13.12M | ($27.14M) | ($27.69M) | $27.60M | $98.88M | $168.33M |
| Financing Cash Flow | ($14.38M) | ($18.21M) | ($9.72M) | ($51.75M) | ($65.04M) | ($9.52M) |
| CapEx | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - |
Ratios
| Metric | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | 6.7% | 6.8% | 10.7% | 8.8% | 10.3% | 9.0% |
| EBITDA margin | 7.8% | 7.6% | 11.5% | 9.4% | 10.9% | 9.6% |
| Net margin | 4.3% | 3.3% | 8.1% | 13.1% | 39.6% | 5.6% |
| Free cash flow margin | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 46.4% | 46.7% | 48.2% | 49.0% | 42.5% | 32.3% |
| Effective tax rate | 36.2% | 50.5% | 23.0% | -48.8% | 7.2% | 37.1% |
| Return on assets | 1.7% | 1.2% | 2.7% | 4.0% | 10.9% | 2.5% |
| Return on equity | 4.0% | 2.7% | 6.3% | 9.7% | 28.2% | 9.3% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | 20.9x | 26.8x |
| Equity multiplier | 2.31 | 2.29 | 2.31 | 2.41 | 2.60 | 3.70 |
| Liabilities / Assets | 0.56 | 0.56 | 0.56 | 0.58 | 0.61 | 0.72 |
| Efficiency | ||||||
| Asset turnover | 0.41 | 0.36 | 0.34 | 0.31 | 0.27 | 0.44 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 18.5% | 6.7% | 9.4% | 3.1% | -41.6% | -0.2% |
| Revenue CAGR (3y) | 11.5% | 6.4% | -13.0% | -15.6% | -18.5% | 7.6% |
| Revenue CAGR (5y) | -3.6% | -6.9% | -9.4% | -5.6% | -2.6% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | 17.8% | -32.5% | 32.5% | -11.6% | -33.5% | 106.7% |
| Net income growth (YoY) | 52.3% | -56.5% | -32.3% | -65.9% | 311.8% | 117.3% |
| EPS growth (YoY) | 54.2% | -56.1% | -28.1% | -62.9% | 314.6% | 85.9% |
| EPS CAGR (3y) | -21.3% | -51.1% | 3.4% | 41.9% | 109.6% | 16.2% |
| EPS CAGR (5y) | -5.6% | -2.0% | 19.7% | 19.3% | - | - |
| FCF growth (YoY) | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 2.2% | 2.4% | 4.0% | -1.1% | 35.0% | 11.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Business segments
$442.52M totalSpecialty Health Segment$224.10M · 50.6%
Group Disability Life DBLAnd PFL$214.77M · 48.5%
Individual Life Annuities And Other Segment$2.41M · 0.5%
Corporate$1.24M · 0.3%
Stability scores
Piotroski F-score
FY 2020 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- -Current ratio improved
- ✓No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Life Insurance
Comparing INDEPENDENCE HOLDING CO against the 5 most active filers in the same SIC group.